EW Stock Overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Edwards Lifesciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$85.84 |
| 52 Week High | US$96.12 |
| 52 Week Low | US$60.57 |
| Beta | 1.07 |
| 1 Month Change | -7.40% |
| 3 Month Change | -0.89% |
| 1 Year Change | -3.22% |
| 3 Year Change | -4.10% |
| 5 Year Change | 43.95% |
| Change since IPO | 6,142.91% |
Recent News & Updates
When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29
Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Recent updates
When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?
Mar 22Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)
Mar 10Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Feb 26Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
Jan 18Edwards Lifesciences: Catalysts For 2023 And Beyond
Dec 30Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 28Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Dec 16Edwards Lifesciences CEO Michael Mussallem to retire
Dec 08Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
Dec 04Shareholder Returns
| EW | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.4% | 1.8% | 3.3% |
| 1Y | -3.2% | 0.6% | 25.8% |
Return vs Industry: EW underperformed the US Medical Equipment industry which returned 0.6% over the past year.
Return vs Market: EW underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| EW volatility | |
|---|---|
| EW Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EW has not had significant price volatility in the past 3 months.
Volatility Over Time: EW's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 19,800 | Bernard Zovighian | www.edwards.com |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve.
Edwards Lifesciences Corporation Fundamentals Summary
| EW fundamental statistics | |
|---|---|
| Market cap | US$51.73b |
| Earnings (TTM) | US$1.41b |
| Revenue (TTM) | US$6.14b |
36.6x
P/E Ratio8.4x
P/S RatioIs EW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EW income statement (TTM) | |
|---|---|
| Revenue | US$6.14b |
| Cost of Revenue | US$1.44b |
| Gross Profit | US$4.71b |
| Other Expenses | US$3.29b |
| Earnings | US$1.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.35 |
| Gross Margin | 76.63% |
| Net Profit Margin | 23.01% |
| Debt/Equity Ratio | 8.3% |
How did EW perform over the long term?
See historical performance and comparison